• News

"New Study on ‘Breakthrough’ Atopic Dermatitis Drug Indicates ‘Eczema Is An Autoimmune Disease’"

  • Inquisitr
  • (February 26, 2015)

Researchers behind a new study on the atopic dermatitis drug “dupilumab” (which is currently in trials) say that they have proven that this form of eczema is an autoimmune disease. The potential atopic dermatitis medication blocks the activity of two key immune proteins, interleukin-4 (IL-4) and interleukin-13 (IL-13), and according to the researchers, can reverse the immune response within an allergic individual that causes the atopic dermatitis skin problems. The promising new atopic dermatitis drug study was led by Emma Guttman-Yassky, MD, Associate Professor of Dermatology at the Icahn School of Medicine at Mount Sinai. Learn more.

Related Articles
Building exterior
AI for Patients
Doctor adjusting microscope
Opioids
Fuster
genes
Doctor adjusting microscope
New York skyscrapers
neuro development
AI in Medicine
Software